Patents by Inventor Chuanbin Shen

Chuanbin Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11953379
    Abstract: A live detection system, a thermal infrared (IR) imager and a method for power grid equipment are provided. The system includes an environmental parameter module for acquiring environmental temperature, humidity and wind speed data; a ranging module for measuring a linear distance to the power grid equipment; an equipment type recognition module for acquiring an image of the power grid equipment, and recognizing a type of the power grid equipment; an equipment material determination module for determining a material type of the power grid equipment; an emissivity setting module for setting an emissivity; an temperature measurement module for obtaining a temperature of the power grid equipment by focusing on positions of the power grid equipment which need temperature measurement; and a report generation module for selecting a corresponding diagnostic model, displaying a temperature measurement position and a temperature value, drawing a conclusion, and generating a report.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: April 9, 2024
    Assignees: State Grid Shandong Electric Power Research Institute, State Grid Corporation of China
    Inventors: Rong Liu, Hui Liu, Qinghe Shen, Jinxia Yao, Haiyan Yuan, Bo Yang, Xiaobin Sun, Chao Gu, Ran Jia, Yang Zhang, Chao Zhou, Chuanbin Liu
  • Publication number: 20190183851
    Abstract: A use of 3,4,7-trihydroxyisoflavone or 3-methoxydaidzein is provided for implementation in preparation of a drug for inhibiting platelet aggregation. The 3,4,7-trihydroxyisoflavone or 3-methoxydaidzein has a significant inhibition effect on platelet aggregation, and bleeding test conducted with these embodiments show that all of the mice administrated with 3,4,7-trihydroxyisoflavone and 3-methoxydaidzein did not show any significant hemorrhagic activity, while the control group, i.e., the group administrated with the same concentration of clopidogrel showed very significant hemorrhagic activity. Thus, the use of such a drug of the present invention is useful in inhibiting platelet aggregation, and the use of such a drug can reduce the risk of bleeding, is safe for use, and expands the clinical and medical applications thereof.
    Type: Application
    Filed: May 3, 2017
    Publication date: June 20, 2019
    Applicant: Kunming Institute of Zoology, Chinese Academy of Sciences
    Inventors: Ren Lai, Chuanbin Shen, Qiumin Lv, Ming Liu